Meningococcal Group B Vaccine 3 strain Brand Name– BEXSERO
What is Meningococcal Group B Vaccine 3 strain
There are 4 different formulations of meningococcal vaccines available: meningococcal polysaccharide vaccine (Menomune); meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra); meningococcal oligosaccharide diphtheria toxoid conjugate vaccine (Menveo); meningococcal recombinant vaccine (Trumenba and Bexsero).
All four vaccines are indicated for the prevention of invasive disease caused by Neisseria meningitis, but they do not all cover the same serogroups.
Prior to prescription or administration, confirm which specific vaccine is desired. Menomune, Menactra, and Menveo are active against serogroups A, C, Y, and W-135, while Trumenba and Bexsero are active against serogroup B.
For additional information on other meningococcal vaccines, see Meningococcal Polysaccharide Vaccine (MPSV4), Meningococcal Conjugate Vaccine (MCV4), or Meningococcal Group B Vaccine (4 strain) content.
- meningococcal infection prophylaxis
- anaphylactoid reactions
- injection site reaction
- laboratory monitoring not necessary
- activities requiring coordination and concentration
- anticoagulant therapy
- corticosteroid therapy
- human immunodeficiency virus (HIV) infection
- latex hypersensitivity
- neoplastic disease
- radiation therapy
- severe combined immunodeficiency (SCID)
- vitamin K deficiency